Clinical trialNCT01175980CompletedPhase 2Interventional

Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma

SponsorNational Cancer Institute (NCI)Enrollment30Recurrent Oral Cavity Adenoid Cystic CarcinomaRecurrent Salivary Gland CarcinomaSalivary Gland Adenoid Cystic CarcinomaStage III Major Salivary Gland Cancer AJCC v7Stage III Oral Cavity Adenoid Cystic Carcinoma AJCC v6 and v7Stage IVA Major Salivary Gland Cancer AJCC v7+6 more conditions

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Patricia LoRusso
Barbara Ann Karmanos Cancer Institute
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada

University Health Network-Princess Margaret Hospital
Toronto, Ontario, Canada

United States

City of Hope Comprehensive Cancer Center
Duarte, California, United States
City of Hope South Pasadena
South Pasadena, California, United States
Yale University
New Haven, Connecticut, United States
National Institutes of Health Clinical Center
Bethesda, Maryland, United States
Wayne State University/karmanos Cancer Institute
Detroit, Michigan, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Case Comprehensive Cancer Center
Cleveland, Ohio, United States
Case Western Reserve University
Cleveland, Ohio, United States
Cleveland Veterans Administration
Cleveland, Ohio, United States
Lake University Ireland Cancer Center
Mentor, Ohio, United States
Ireland Cancer Center at Firelands Regional Medical Center
Sandusky, Ohio, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 6 Aug 2010
Primary completion: 8 Jun 2018
Completion: 1 Aug 2018
Last update posted: 3 Aug 2020
Registered enrollment: 30
Registry id: NCT01175980

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.